Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates (2018)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1016/j.adaj.2017.12.028
- Subjects: LESÕES CANCERIZÁVEIS; MIELOMA MÚLTIPLO; FATORES DE RISCO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the american dental association
- ISSN: 0002-8177
- Volume/Número/Paginação/Ano: v. 149, n. 5, p. 382-391, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FARIA, Karina Morais e PEREIRA, Juliana. Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates. Journal of the american dental association, v. 149, n. 5, p. 382-391, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.adaj.2017.12.028. Acesso em: 12 jan. 2026. -
APA
Faria, K. M., & Pereira, J. (2018). Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates. Journal of the american dental association, 149( 5), 382-391. doi:10.1016/j.adaj.2017.12.028 -
NLM
Faria KM, Pereira J. Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates [Internet]. Journal of the american dental association. 2018 ; 149( 5): 382-391.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.adaj.2017.12.028 -
Vancouver
Faria KM, Pereira J. Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates [Internet]. Journal of the american dental association. 2018 ; 149( 5): 382-391.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.adaj.2017.12.028 - Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study
- A difficult case of angioimmunoblastic T-cell lymphoma to diagnose
- Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era
- Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes
- Estudo de células precuroras em leucemias agudas: identificação e fator de prognóstico das proteínas Bcl-2, Bax e CD95/Fas/APO-1
- Panoramic and skull imaging may aid in the identification of multiple myeloma lesions
- Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study
- Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University
Informações sobre o DOI: 10.1016/j.adaj.2017.12.028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
